SURMODICS INC — Director's Dealing 2022

Feb 14, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2022-02-10

Reporting Person: DANTZKER DAVID (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-10	Common Stock	A	1375	$0.00	Acquired	32585	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-10	Stock Option (right to buy)	$41.81	A	3555	Acquired	2029-02-10	Common Stock (3555)	Direct

Footnotes

F1: The amount beneficially owned includes 11,985 restricted stock units (RSUs) that vest on service-based vesting dates and 15,415 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.

F2: The stock options vest ratably on a monthly basis and become fully vested on February 10, 2023, the 12-month anniversary of the grant date.